Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study.
Su Jong YuYun Bin LeeEun-Ju ChoJeong-Hoon LeeHyo Cheol KimJin Wook ChungJung Hwan YoonYun Joon KimPublished in: Journal of liver cancer (2023)
DEB-TACE may be a therapeutic option for advanced HCC patients with PVI.